Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Farmers Insurance
Colorcon
Express Scripts
Daiichi Sankyo
AstraZeneca

Generated: July 22, 2019

DrugPatentWatch Database Preview

Litigation Details for NOVARTIS PHARMACEUTICALS CORPORATION v. ACTAVIS LLC (D.N.J. 2013)

Try a free trialSee Plans and Pricing

« Back to Dashboard

NOVARTIS PHARMACEUTICALS CORPORATION v. ACTAVIS LLC (D.N.J. 2013)

Docket ➤ Try a Free Trial Date Filed 2013-02-20
Court District Court, D. New Jersey Date Terminated 2013-05-22
Cause 35:271 Patent Infringement Assigned To Susan Davis Wigenton
Jury Demand Defendant Referred To Madeline Cox Arleo
Parties ACS DOBFAR INFO S.A.; ACTAVIS LLC; AGILA SPECIALITIES PRIVATE LTD.; AGILA SPECIALTIES PRIVATE LTD.; APOTEX CORP.; APOTEX, INC.; BEDFORD LABORATORIES, INC.; CARACO PHARMACEUTICAL LABORATORIES, LTD.; DR. REDDY'S LABORATORIES LTD.; DR. REDDY'S LABORATORIES, INC.; EMCURE PHARMACEUTICALS USA, INC.; EMCURE PHARMACEUTICALS USA, INC.; EMCURE PHARMACEUTICALS, LTD; GLAND PHARMA LTD.; HOSPIRA, INC.; NOVARTIS PHARMACEUTICALS CORPORATION; PHARMACEUTICS INTERNATIONAL INC.; PHARMAFORCE, INC.; SAGENT PHARMACEUTICALS, INC.; STRIDES, INC.; SUN PHARMA GLOBAL FZE; SUN PHARMACEUTICAL INDUSTRIES LTD.; SUN PHARMACEUTICALS INDUSTRIES, INC.; TEVA PARENTERAL MEDICINES, INC.; WOCKHARDT LTD.; WOCKHARDT USA LLC
Patents 6,926,907; 7,932,241; 8,052,987; 8,324,189
Attorneys AJAY KAYAL; ALAN HENRY POLLACK; ANDREW J. MILLER; ANDREW P. NEMIROFF; ANTHONY J LAURA; BRUCE D. RADIN; CHRISTOPHER ROBERT KINKADE; DIANE C. RAGOSA; DMITRY V. SHELHOFF; ERICA SUSAN HELMS; GREGORY D. MILLER; JAMES S. RICHTER; JASON B. LATTIMORE; JAY R. DESHMUKH; JEFFREY A. COHEN; JULIE E. KURZROK; KAREN A. CONFOY; MARILYN NEIMAN; MELISSA STEEDLE BOGAD; NANCY ANN DEL PIZZO; PHILIP L. HIRSCHHORN; RACHEL WEINER COHEN; SARAH CHRISTINE MITCHELL; STEVEN J. LEE; THOMAS A. CUNNIFF; WILLIAM J. O'SHAUGHNESSY
Firms Budd Larner PC; Budd Larner, P.C.; Budd Larner, PC; Connell, Foley; Jeffrey A. Cohen; Kenyon & Kenyon LLP; Law Office of Jason B. Lattimore, Esq.; Rivkin Radler LLP
Link to Docket External link to docket
Small Molecule Drugs cited in NOVARTIS PHARMACEUTICALS CORPORATION v. ACTAVIS LLC
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , and ➤ Try a Free Trial .

Details for NOVARTIS PHARMACEUTICALS CORPORATION v. ACTAVIS LLC (D.N.J. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-02-20 1 . 7,932,241 (“the ‘241 patent”) directed to certain approved presentations for zoledronic acid. 5. Upon…Novartis’ patent rights can be enforced 4. The three patents awarded to Novartis by the U.S. Patent and Trademark…are: U.S. Patent No. 8,324,189 (“the ‘189 patent”) directed to oncology methods, U.S. Patent No. 8,052,987…ACTION 2. This is an action for patent infringement under the patent laws of the United States, Title…987 patent”) directed to methods for treating abnormally increased bone turnover, and U.S. Patent No. External link to document
2013-03-27 146 Exhibit 2 one Pozen patent (U.S. Patent 6,926,907—“the ‘907 patent”) and five AstraZeneca patents (not at issue… responses with regard to the ‘907 patent only. The ‘907 patent has 55 claims. On November 17, 2011…907 patent. Subsequently, Plaintiffs further narrowed their asserted claims of the ‘907 patent to …VIMOVO® drug prior to the expiration of Plaintiffs’ patents. Id. DRL is the first ANDA filer for…dkt. nos. 41 and 82. A. The ‘907 Patent Plaintiffs seek leave to amend their External link to document
2013-04-30 225 Declaration of Karen A. Confoy in Support of Defendants' Opposition to Plai relating to United States Patent No. 7,932,241 (the "'24l patent"). This disclosure… of "plastic materia|" in U.S. Patent No. 7,932,241 as "any of various organic compounds…for the final disputed claim term in the '241 patent. I declare under penalty of perjury under…PURSUANT To NEW JERSEY LOCAL PATENT RULE 3_6(b) Case 2:13-cv-01028-SDW-MCA Document…of 13 PageID: 6159 Pursuant to Local Patent Rule 3.6(b), Plaintiffs Novartis Pharmaceuticals External link to document
2013-05-13 236 respect to U.S. Patent Nos. 7,932,241 and 8,052,987. Hospira alleged that these patents are invalid, …must include, among other things, the patent number of any patent that claims the drug or a method of… THE ’241 PATENT 14. The ’241 patent was issued on April 26, 2011, to…of using” zoledronic acid and is a patent for which a claim of patent infringement could reasonably … THE ’987 PATENT 20. The ’987 patent was issued on November 8, 2011, External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Argus Health
US Army
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.